The Conversation (0)
Jan 05, 2026
Top 5 Small-cap Pharma Stocks (Updated January 2026)
More Featured Articles and Inverviews
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Latest News
Latest News
Outlook Reports world
Featured Pharmaceutical Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.